Matthew Phipps
Stock Analyst at William Blair
(0.12)
# 3,288
Out of 4,479 analysts
4
Total ratings
25%
Success rate
-33%
Average return
Main Sectors:
Top Industries:
4 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMGN Amgen | Upgrades: Outperform | n/a | $310.77 | - | 1 | May 3, 2024 | |
| NAMS NewAmsterdam Pharma Company | Initiates: Outperform | n/a | $20.30 | - | 1 | Dec 19, 2022 | |
| IKNA Ikena Oncology | Initiates: Outperform | n/a | $1.63 | - | 1 | Apr 20, 2021 | |
| PIRS Pieris Pharmaceuticals | Initiates: Outperform | n/a | $8.57 | - | 1 | Jan 17, 2018 |
Amgen
May 3, 2024
Upgrades: Outperform
Price Target: n/a
Current: $310.77
Upside: -
NewAmsterdam Pharma Company
Dec 19, 2022
Initiates: Outperform
Price Target: n/a
Current: $20.30
Upside: -
Ikena Oncology
Apr 20, 2021
Initiates: Outperform
Price Target: n/a
Current: $1.63
Upside: -
Pieris Pharmaceuticals
Jan 17, 2018
Initiates: Outperform
Price Target: n/a
Current: $8.57
Upside: -